New Drug Combo Helps Treat Chronic Hepatitis C
(Ivanhoe Newswire) –Treatment of chronic hepatitis C virus (HCV) genotype 1 infection with the interferon-free regimen of sofosbuvir and ribavirin resulted in a high sustained virologic response rate in a patient population with unfavorable treatment characteristics, according to recent research.
“This study demonstrates the efficacy of an interferon-free regimen in a traditionally difficult-to-treat population while exploring the reasons for treatment relapse. In this study, treatment of chronic HCV infection with a single directly acting antiviral agent (sofosbuvir) and weight-based ribavirin resulted in a high SVR rate in a population with unfavorable traditional predictors of treatment response compared with reported rates with currently used interferon-based therapy in similar populations,” Anuoluwapo Osinusi, MD, MPH, of the National Institutes of Health, Bethesda, Md., was quoted as saying.
For more information, go to: http://media.jamanetwork.com/news-item/combination-drug-regimen-appears-beneficial-for-patients-with-hepatitis-c-and-unfavorable-treatment-characteristics/
SOURCE: JAMA, August 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.